Cytogenetic characterization of head and neck squamous cell carcinoma cell lines as model systems for the functional analyses of tumor-associated genes

Journal of Oral Pathology and Medicine

Volumn 39, Issue 5, 2010, Pages 382-389

  Freier, Kolja ^a,b   Hofele, Christof ^b   Knoepfle, Karl ^c   Gross, Madeleine ^a   Devens, Frauke ^a   Dyckhoff, Gerhard ^d   Plinkert, Peter ^d   Lichter, Peter ^a   Herold Mende, Christel ^b,d  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c PAUL EHRLICH INSTITUT   (Germany)

^d Klinik für Hals Nasen Ohren Heilkunde   (Germany)

Author keywords

CCND1; Chromosomal CGH; CTTN; FISH; HNSCC cell lines

Indexed keywords

CYCLIN D1; ONCOPROTEIN; PROTEIN CTTN; TUMOR ANTIGEN; UNCLASSIFIED DRUG; CORTACTIN; CTTN PROTEIN, HUMAN; MESSENGER RNA; TUMOR PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CHROMOSOME 11Q; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE NUMBER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC GAIN; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; BIOLOGICAL MODEL; BIOSYNTHESIS; CHROMOSOME 11; GENE DOSAGE; GENETICS; HEAD AND NECK TUMOR; METABOLISM; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 11; COMPARATIVE GENOMIC HYBRIDIZATION; CORTACTIN; CYCLIN D1; GENE DOSAGE; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MODELS, GENETIC; NEOPLASM PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77951269689     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2009.00864.x     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007 57 : 43 66. (Pubitemid 46148091)
2. Knuutila S, Autio K, Aalto Y. Online access to CGH data of DNA sequence copy number changes. Am J Pathol 2000 157 : 689 690.
3. Bockmuhl U, Schluns K, Kuchler I, et al. Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 2000 157 : 369 375. (Pubitemid 30627556)
4. Freier K, Sticht C, Hofele C, et al. Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 2006 45 : 118 125. (Pubitemid 43191018)
5. Jarvinen AK, Autio R, Kilpinen S, et al. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes Chromosomes Cancer 2008 47 : 500 509. (Pubitemid 351657185)
6. Sparano A, Quesnelle KM, Kumar MS, et al. Genome-wide profiling of oral squamous cell carcinoma by array-based comparative genomic hybridization. Laryngoscope 2006 116 : 735 741. (Pubitemid 44318029)
7. Bauer VL, Braselmann H, Henke M, et al. Chromosomal changes characterize head and neck cancer with poor prognosis. J Mol Med 2008 86 : 1353 1365.
8. Wreesmann VB, Shi W, Thaler HT, et al. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 2004 22 : 3965 3972. (Pubitemid 41079879)
9. Rickman DS, Millon R, De Reynies A, et al. Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays. Oncogene 2008 27 : 6607 6622.
10. Liu CJ, Liu TY, Kuo LT, et al. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma. J Pathol 2008 214 : 489 497. (Pubitemid 351340569)
11. Dumur CI, Ladd AC, Wright HV, et al. Genes involved in radiation therapy response in head and neck cancers. Laryngoscope 2009 119 : 91 101.
12. Schlecht NF, Burk RD, Adrien L, et al. Gene expression profiles in HPV-infected head and neck cancer. J Pathol 2007 213 : 283 293. (Pubitemid 350074018)
13. Sticht C, Freier K, Knopfle K, et al. Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). Neoplasia 2008 10 : 462 470. (Pubitemid 351657388)
14. Ninck S, Reisser C, Dyckhoff G, et al. Expression profiles of angiogenic growth factors in squamous cell carcinomas of the head and neck. Int J Cancer 2003 106 : 34 44. (Pubitemid 36750385)
15. Nessling M, Solinas-Toldo S, Wilgenbus KK, et al. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998 23 : 307 316. (Pubitemid 28507370)
16. Freier K, Flechtenmacher C, Walch A, et al. Copy number gains on 22q13 in adenoid cystic carcinoma of the salivary gland revealed by comparative genomic hybridization and tissue microarray analysis. Cancer Genet Cytogenet 2005 159 : 89 95. (Pubitemid 40614728)
17. Du Manoir S, Schrock E, Bentz M, et al. Quantitative analysis of comparative genomic hybridization. Cytometry 1995 19 : 27 41.
18. Korz C, Pscherer A, Benner A, et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood 2002 99 : 4554 4561. (Pubitemid 34627227)
19. Schwaenen C, Nessling M, Wessendorf S, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations. Proc Natl Acad Sci USA 2004 101 : 1039 1044. (Pubitemid 38160580)
20. Lichter P, Tang CJ, Call K, et al. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 1990 247 : 64 9.
21. Sticht C, Hofele C, Flechtenmacher C, et al. Amplification of Cyclin L1 is associated with lymph node metastases in head and neck squamous cell carcinoma (HNSCC). Br J Cancer 2005 92 : 770 774. (Pubitemid 40460616)
22. Vasvari GP, Dyckhoff G, Kashfi F, et al. Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo. Int J Cancer 2007 121 : 1697 1704. (Pubitemid 47417285)
23. Ashman JN, Patmore HS, Condon LT, et al. Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 2003 89 : 864 869. (Pubitemid 37175809)
24. Huang X, Gollin SM, Raja S, et al. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Natl Acad Sci USA 2002 99 : 11369 11374. (Pubitemid 34920932)
25. Huang X, Godfrey TE, Gooding WE, et al. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 2006 45 : 1058 1069. (Pubitemid 44435540)
26. Fu M, Wang C, Li Z, et al. Minireview: Cyclin D1: normal and abnormal functions. Endocrinology 2004 145 : 5439 5447. (Pubitemid 39564581)
27. Akervall J, Borg A, Dictor M, et al. Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck. Int J Oncol 2002 20 : 45 52.
28. Akervall JA, Michalides RJ, Mineta H, et al. Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 1997 79 : 380 389. (Pubitemid 27029903)
29. Tan KD, Zhu Y, Tan HK, et al. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma. Genes Chromosomes Cancer 2008 47 : 353 362. (Pubitemid 351323765)
30. Rodrigo JP, Garcia LA, Ramos S, et al. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 2000 6 : 3177 3182. (Pubitemid 30637745)
31. Rodrigo JP, Garcia-Carracedo D, Garcia LA, et al. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 2009 217 : 516 523.
32. Gibcus JH, Mastik MF, Menkema L, et al. Cortactin expression predicts poor survival in laryngeal carcinoma. Br J Cancer 2008 98 : 950 955. (Pubitemid 351341606)
33. Rothschild BL, Shim AH, Ammer AG, et al. Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 2006 66 : 8017 8025.
34. Samuels Y, Ericson K. Oncogenic PI3K and its role in cancer. Curr Opin Oncol 2006 18 : 77 82. (Pubitemid 43740454)
35. Woenckhaus J, Steger K, Werner E, et al. Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 2002 198 : 335 342. (Pubitemid 35277384)
36. Liu CJ, Lin SC, Chen YJ, et al. Array-comparative genomic hybridization to detect genomewide changes in microdissected primary and metastatic oral squamous cell carcinomas. Mol Carcinog 2006 45 : 721 731.
37. Verdier AS, Mattei MG, Lovec H, et al. Chromosomal mapping of two novel human FGF genes, FGF11 and FGF12. Genomics 1997 40 : 151 154. (Pubitemid 27108261)
38. Smallwood PM, Munoz-Sanjuan I, Tong P, et al. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci USA 1996 93 : 9850 9857. (Pubitemid 26296698)
39. Chen J, Guo L, Peiffer DA, et al. Genomic profiling of 766 cancer-related genes in archived esophageal normal and carcinoma tissues. Int J Cancer 2008 122 : 2249 2254. (Pubitemid 351542327)
40. Van Der Horst EH, Degenhardt YY, Strelow A, et al. Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci USA 2005 102 : 15901 15906. (Pubitemid 41552840)
41. Mahajan NP, Liu Y, Majumder S, et al. Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci USA 2007 104 : 8438 8443. (Pubitemid 47175506)
42. Howlin J, Rosenkvist J, Andersson T. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells. Breast Cancer Res 2008 10 : R36.
43. Weiss MM, Snijders AM, Kuipers EJ, et al. Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization. J Pathol 2003 200 : 320 326.
44. Freier K, Joos S, Flechtenmacher C, et al. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma. Cancer Res 2003 63 : 1179 1182. (Pubitemid 36348691)
45. Barlund M, Monni O, Weaver JD, et al. Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer. Genes Chromosomes Cancer 2002 35 : 311 317. (Pubitemid 35246989)
46. Frank CJ, Mcclatchey KD, Devaney KO, et al. Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res 1997 57 : 824 827.
47. Takebayashi S, Hickson A, Ogawa T, et al. Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer. Genes Chromosomes Cancer 2004 41 : 145 154. (Pubitemid 39096740)
48. Takebayashi S, Ogawa T, Jung KY, et al. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 2000 60 : 3397 3403. (Pubitemid 30482154)
49. Blons H, Laccourreye O, Houllier AM, et al. Delineation and candidate gene mutation screening of the 18q22 minimal region of deletion in head and neck squamous cell carcinoma. Oncogene 2002 21 : 5016 5023.